Recherche
-
Myocardial infarction associated with erenumab: a case report.
(PHARMACOTHERAPY, 2022-05-27)Article de revueLibre accès -
Second-degree burn induced by high-concentration topical capsaicin with mobility sequelae: a case report
(Pain Practice. vol. 23, n° 2, pp. 216-219, 2023-02)Article de revueLibre accès -
Validation of Artificial Intelligence to Support the Automatic Coding of Patient Adverse Drug Reaction Reports, Using Nationwide Pharmacovigilance Data
(Drug Safety. vol. 45, n° 5, pp. 535-548, 2022-05)Article de revueLibre accès -
Safety Profile of Ibrutinib: An Analysis of the WHO Pharmacovigilance Database
(Frontiers in Pharmacology. vol. 12, pp. 769315, 2021-10-28)Article de revueLibre accès -
Safety of Anti-Angiogenic Drugs in Pediatric Patients with Solid Tumors: A Systematic Review and Meta-Analysis
(Cancers. vol. 14, n° 21, 2022-10-28)Article de revueLibre accès -
Safety of Dual Orexin Receptor Antagonist Daridorexant: A Disproportionality Analysis of Publicly Available FAERS Data
(Pharmaceuticals (Basel). vol. 17, n° 3, 2024-03-06)Article de revueLibre accès -
Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study
(Clinical Genitourinary Cancer. vol. 22, n° 2, pp. 295-304, 2023-11-24)Article de revueLibre accès -
Artificial intelligence for unstructured healthcare data: application to coding of patient reporting of adverse drug reactions
(Clinical Pharmacology and Therapeutics, 2021-04-18)Article de revueLibre accès -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
(Frontiers in Pharmacology. vol. 10, pp. 265, 2019-03)Article de revueLibre accès